Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4854350
Max Phase: Preclinical
Molecular Formula: C29H39NO9
Molecular Weight: 545.63
Molecule Type: Unknown
Associated Items:
ID: ALA4854350
Max Phase: Preclinical
Molecular Formula: C29H39NO9
Molecular Weight: 545.63
Molecule Type: Unknown
Associated Items:
Canonical SMILES: COC(=O)[C@@H]1C[C@@H](O[C@H]2O[C@@H]3O[C@@]4(C)CC[C@H]5[C@H](C)CC[C@@H]([C@H]2C)[C@@]35OO4)CN1C(=O)OCc1ccccc1
Standard InChI: InChI=1S/C29H39NO9/c1-17-10-11-22-18(2)25(36-26-29(22)21(17)12-13-28(3,37-26)38-39-29)35-20-14-23(24(31)33-4)30(15-20)27(32)34-16-19-8-6-5-7-9-19/h5-9,17-18,20-23,25-26H,10-16H2,1-4H3/t17-,18-,20-,21+,22+,23+,25+,26-,28-,29-/m1/s1
Standard InChI Key: GBSKRNBAVNHRNS-YDRPBWNPSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 545.63 | Molecular Weight (Monoisotopic): 545.2625 | AlogP: 4.16 | #Rotatable Bonds: 5 |
Polar Surface Area: 101.99 | Molecular Species: NEUTRAL | HBA: 9 | HBD: 0 |
#RO5 Violations: 1 | HBA (Lipinski): 10 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 4.85 | CX LogD: 4.85 |
Aromatic Rings: 1 | Heavy Atoms: 39 | QED Weighted: 0.40 | Np Likeness Score: 1.83 |
1. Aratikatla EK, Kalamuddin M, Rana KC, Datta G, Asad M, Sundararaman S, Malhotra P, Mohmmed A, Bhattacharya AK.. (2021) Combating multi-drug resistant malaria parasite by inhibiting falcipain-2 and heme-polymerization: Artemisinin-peptidyl vinyl phosphonate hybrid molecules as new antimalarials., 220 [PMID:33901900] [10.1016/j.ejmech.2021.113454] |
Source(1):